VOYAGER ACQUISITION CORP UNIT 1 COM & 1/2 WT EXP

11.50

0.0000

Volume:- -

Turnover:- -

Market Cap:354.20M

PE:- -

High:11.50

Open:11.50

Low:11.50

Close:11.50

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

GlobeNewswire

·

06 May

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VACHU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VACHU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VACHU\",,,,,undefined,":{"symbol":"VACHU","market":"US","secType":"STK","nameCN":"VOYAGER ACQUISITION CORP UNIT 1 COM & 1/2 WT EXP","latestPrice":11.5,"timestamp":1752868800000,"preClose":11.5,"halted":0,"volume":0,"delay":0,"floatShares":25300000,"shares":30800000,"eps":0,"marketStatus":"Market Closed","change":0,"latestTime":"07-18 16:00:00 EDT","open":11.5,"high":11.5,"low":11.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"listingDate":1723176000000,"exchange":"NASDAQ","adjPreClose":11.5,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VACHU\",,,,,undefined,":{"symbol":"VACHU","floatShares":25300000,"roa":"--","roe":"--","lyrEps":0,"shares":30800000,"dividePrice":0,"high":11.5,"amplitude":0,"preClose":11.5,"low":11.5,"week52Low":9.97,"pbRate":"-30.46","week52High":11.5,"institutionHeld":0,"latestPrice":11.5,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":11.5,"prevYearClose":10.12,"prevWeekClose":11.5,"prevMonthClose":10.45,"prevQuarterClose":10.45,"fiveDayClose":11.5,"twentyDayClose":10.45,"sixtyDayClose":10.24},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VACHU\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VACHU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533558142","title":"VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2533558142","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533558142?lang=en_us&edition=fundamental","pubTime":"2025-05-06 00:59","pubTimestamp":1746464340,"startTime":"0","endTime":"0","summary":"Partnership Combines VERAXA's Proprietary ADC Technology with OmniAb's Antibody Discovery Technology for Novel Therapies Targeting Solid Tumors. ZURICH, SWITZERLAND, May 05, 2025  -- VERAXA Biotech AG , an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target ofVoyager Acquisition Corp. , announced today a co-discovery alliance with OmniAb, Inc.  for the development of a novel bispecific antibody drug conjugate  program targeting solid tumors. The collaboration brings together OmniAb’s suite of transgenic antibody discovery solutions with VERAXA’s proprietary antibody drug conjugate  linker technology and conjugation expertise to support next-generation therapeutic discovery.At VERAXA, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific ADCs, bispecific T cell engagers and other innovative formats. Powered by a suite of transformative technologies and guided by rigo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/veraxa-biotech-enters-co-discovery-165900881.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","OABIW","MNQmain","QID","TSYW.SI","USAW.SI","BK4121","TQQQ","NVIW.SI","OABI","USJW.SI","VACHW","PSQ","VACHU","VACH","QLD","NQmain",".IXIC"],"gpt_icon":1}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VACHU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"VACHU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VACHU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VACHU\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VACHU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VACHU","date":"2025-06-04","current":49.299553,"percent":0.232558,"low":49.108655,"twenty":49.232739,"median":77.967236,"eighty":78.532327,"high":78.730872,"avg":70.34131,"sd":12.938874,"marketCap":326686250},"quantilePoints":[{"date":"2025-04-04","current":77.890872,"twenty":77.890872,"median":77.890872,"eighty":77.890872,"marketCap":322575000},{"date":"2025-04-11","current":78.196327,"twenty":77.890872,"median":77.890872,"eighty":78.089418,"marketCap":323840000},{"date":"2025-04-17","current":77.967236,"twenty":77.890872,"median":77.967236,"eighty":78.10469,"marketCap":322891250},{"date":"2025-04-25","current":78.27269,"twenty":77.890872,"median":77.967236,"eighty":78.181054,"marketCap":324156250},{"date":"2025-05-02","current":78.501781,"twenty":77.906145,"median":78.005418,"eighty":78.27269,"marketCap":325105000},{"date":"2025-05-09","current":78.578145,"twenty":77.967236,"median":78.196327,"eighty":78.464821,"marketCap":325421250},{"date":"2025-05-16","current":78.730872,"twenty":77.967236,"median":78.27269,"eighty":78.578145,"marketCap":326053750},{"date":"2025-05-23","current":49.204104,"twenty":77.890872,"median":78.196327,"eighty":78.578145,"marketCap":326053750},{"date":"2025-05-30","current":49.204104,"twenty":49.251829,"median":78.0436,"eighty":78.578145,"marketCap":326053750},{"date":"2025-06-04","current":49.299553,"twenty":49.232739,"median":77.967236,"eighty":78.532327,"marketCap":326686250}],"updateTime":1752946685296}}}